RHB Retail Research
Trading Stocks- Duopharma Biotech
Duopharma Biotech attempted to cross above the MYR1.67 resistance in the latest session. An upside breach of this level, which coincides with the rising 21-day SMA line, could see the stock testing the MYR1.75 resistance, followed by MYR1.80. A stop-loss can be placed below MYR1.65.
Source: RHB Securities Research - 17 Jun 2020
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
The Alpha Trader
3
Rakuten Trade Research Reports
4
南洋行家论股
7
BFM Podcast
8
TA Sector Research
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
